Nervous system

Global Salmon Market (2021 to 2028) - Rise in Fish Production to Meet Food Supply is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 21, 2021
Food, Beverage, Retail, People, Benchmarking, Animal rights, Industry, Hypertension, United Nations, Crescent Porter Hale, Salmon (color), Obesity, Child, Calcium, Risk, First Nations in Ontario, Atherosclerosis, People for the Ethical Treatment of Animals, Growth, CAGR, PETA, Stroke, Awareness, Cell, Nervous system, Distribution, Non-governmental organization, Phosphorus, Aquaculture

In addition, most Atlantic salmon are available in the global market are farmed, whereas the majority of Pacific salmon are wild-caught.

Key Points: 
  • In addition, most Atlantic salmon are available in the global market are farmed, whereas the majority of Pacific salmon are wild-caught.
  • The growing demand for salmon in emerging markets like Asia-Pacific and Latin America is offering lucrative growth opportunities to the players operating in the global salmon market.
  • Moreover, demand for eco-labelled farmed salmon is rising rapidly and preference for fresh food products is trending in the salmon market.
  • The report provides a quantitative analysis of the current market, estimations, trends, and dynamics of the global salmon market size from 2020 to 2028 to identify the prevailing market opportunities.

University of Maryland School of Medicine Neurology Chair Peter B. Crino, MD, PhD, Receives Prestigious Neuroscience Award

Retrieved on: 
Thursday, October 21, 2021
Gene, NIH, Partnership, National, History of the University of Maryland, College Park, Department of Neurology, Xuanwu hospital, Intellectual disability, Amyotrophic lateral sclerosis, Doctor of Philosophy, Congress, RNA transfection, Research, Kwan Um School of Zen, Association, National academy, MBA, NINDS, Faculty, Lists of diseases, Brain, University of Maryland School of Medicine, National Academy of Medicine, Professor, Tissue, Medical research, TSC, Nervous system, Association of American Medical Colleges, News, MTOR, Institute, Epilepsy, Department, Physician, Science, Medical Affairs Bureau, U.S. News & World Report, School, Maryland School, Population, ALS, Health, DNA, Student, University, Patient, University of Maryland Medical Center, Autism, Management, Pharmaceutical industry

Senator Javits was a strong advocate for support of research in a wide variety of disorders of the brain and nervous system.

Key Points: 
  • Senator Javits was a strong advocate for support of research in a wide variety of disorders of the brain and nervous system.
  • The Javits Award will greatly augment our lab progress and productivity in these critical areas of research," he said.
  • Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States.
  • The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world.

Aptinyx Appoints Gilmore O’Neill, M.B., M.M.Sc., to Board of Directors

Retrieved on: 
Wednesday, October 20, 2021
Mental Health, Health, General Health, Research, Science, Pharmaceutical, Biotechnology, Biotechnology, Multiple sclerosis, Connective tissue disease, Neurology, Pharmacovigilance, Pain, University College Dublin, Chronic pain, Twitter, Private Securities Litigation Reform Act, Hospital, U.S. Securities and Exchange Commission, Medicine, Sarepta, Security (finance), Harvard Medical School, Degenerative disease, Government budget balance, Sarepta Therapeutics, Massachusetts, Annual report, Department, Central nervous system, Nervous system, Research, Leadership, Nasdaq, Massachusetts General Hospital, Harvard University, Biogen, Therapy, Lists of diseases, Neuromuscular disease, Patient, Bachelor of Medicine, Bachelor of Surgery, Brain, NMDA, Inc., Department of Neurobiology, Harvard Medical School, Science, Post-traumatic stress disorder, Movement disorders, Unity Biotechnology, APTX, Pharmaceutical industry, Management

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced the appointment of Gilmore ONeill, M.B., M.M.Sc., to the companys board of directors.

Key Points: 
  • Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced the appointment of Gilmore ONeill, M.B., M.M.Sc., to the companys board of directors.
  • Gilmore brings an exceptional background of experience and leadership to the Aptinyx board of directors, said Norbert Riedel, Ph.D., chief executive officer of Aptinyx.
  • I am confident that Gilmore will serve as an invaluable resource to Aptinyx as we continue to develop new therapeutic options for patients living with nervous system disorders.
  • He serves on the board of the Massachusetts Biotechnology Council and on the board of directors of Unity Biotechnology.

Space: Science & Technology Article Explains Why Astronauts Are Vulnerable to Depression

Retrieved on: 
Tuesday, October 19, 2021
Biomarker, Depression, Circadian rhythm, Synapse, Beijing Institute of Technology, Science, Noise, Appetite, RATS, Nervous system, Research, Travel, Astronaut, Hippocampus, Brain, Neurotransmission, Proteomics, Protein, Meat, Motivation, Animal, Aluminium

By now, it is well established that prolonged exposure to the harsh conditions of space environments is harmful to the mind and body.

Key Points: 
  • By now, it is well established that prolonged exposure to the harsh conditions of space environments is harmful to the mind and body.
  • Besides bone and muscle problems, cardiovascular complications, and immune system malfunctioning, staying in space for too long can cause depression in astronauts.
  • The study was published online in Space: Science & Technology on 27 May 2021.
  • Hopefully, science will let us find ways to prevent space travel from taking a toll on astronauts' minds and bodies.

Intetics Team Has Developed A New Application That Helps Surgeons Navigate Neural Implant Insertion

Retrieved on: 
Friday, October 15, 2021
Nervous system, Central nervous system, C, CT, Association of British HealthTech Industries, Technology, MRI, CNS, Machine learning, 3D, Case, VTK, Client, Algorithm, Case study, Memory, Tissue, AI, Knowledge, Multithreading, FDA, Programmer, Patient, Surgeon, GLOBE, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, Thought, ML, API, Intetics, DICOM, Stroke, Software, Research, Brain, Defense, MPR, Dentistry, Medical device, Medical imaging

Why Neural Implant Insertion Needs ML and AI.

Key Points: 
  • Why Neural Implant Insertion Needs ML and AI.
  • This is responsible for our seeing, thinking, moving, and feeling and it controls our cardiovascular, inflammatory, respiratory, and immune systems.
  • The application needed to assist surgeons by navigating during implant insertion.
  • With the help of this application, surgeons are able to insert the Clients neural implant in a much safer, more informed manner thus giving hope to the millions of people suffering from stroke symptoms.

MindMaze and The Royal Buckinghamshire Hospital pioneer first U.K. location-based digital therapeutic solution for brain repair

Retrieved on: 
Thursday, October 14, 2021
Nervous system, Lighting, Alzheimer's disease, Traumatic brain injury, Technology, Dolphin, Ageing, Lists of diseases, Solution, Rehabilitation, Environment, CE, Department of Neurology, Xuanwu hospital, Single-frequency network, Adoption, Royal Buckinghamshire Hospital, Pixar, Department, Engineering, Johns Hopkins School of Medicine, FDA, Multimedia, Movement, Artificial intelligence, Health, Clinical trial, Patient, Dementia, Neuroscience, U.S. Department of Defense Strategy for Operating in Cyberspace, Arm, Neuro, RBH, CEO, Stroke, Unicorn, Nursing, Parkinson's disease, Partnership, Finger, Encarta, Medical imaging, Pharmaceutical industry

MindPod is the world's first immersive neuro-animation experience a unique form of location-based digital therapeutic that focuses on brain repair through high intensity and high dose complex exploratory movements.

Key Points: 
  • MindPod is the world's first immersive neuro-animation experience a unique form of location-based digital therapeutic that focuses on brain repair through high intensity and high dose complex exploratory movements.
  • Based on technology developed by Johns Hopkins University School of Medicine's Department of Neurology, it is an evidence-based, protocolized, FDA-listed, and CE-Marked neurorestorative solution.
  • "It is a Pixar-level experience which recreates the enriched environments that neuroscience has shown to be beneficial in animal models."
  • MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt.

MindMaze and The Royal Buckinghamshire Hospital pioneer first U.K. location-based digital therapeutic solution for brain repair

Retrieved on: 
Thursday, October 14, 2021
Nervous system, Lighting, Alzheimer's disease, Traumatic brain injury, Technology, Dolphin, Ageing, Lists of diseases, Solution, Rehabilitation, Environment, CE, Department of Neurology, Xuanwu hospital, Single-frequency network, Adoption, Royal Buckinghamshire Hospital, Pixar, Department, Engineering, Johns Hopkins School of Medicine, FDA, Movement, Artificial intelligence, Health, Clinical trial, Patient, Dementia, Neuroscience, U.S. Department of Defense Strategy for Operating in Cyberspace, Arm, Neuro, RBH, CEO, Stroke, Unicorn, Nursing, Parkinson's disease, Partnership, Finger, Encarta, Medical imaging, Pharmaceutical industry

MindPod is the world's first immersive neuro-animation experience a unique form of location-based digital therapeutic that focuses on brain repair through high intensity and high dose complex exploratory movements.

Key Points: 
  • MindPod is the world's first immersive neuro-animation experience a unique form of location-based digital therapeutic that focuses on brain repair through high intensity and high dose complex exploratory movements.
  • Based on technology developed by Johns Hopkins University School of Medicine's Department of Neurology, it is an evidence-based, protocolized, FDA-listed, and CE-Marked neurorestorative solution.
  • "It is a Pixar-level experience which recreates the enriched environments that neuroscience has shown to be beneficial in animal models."
  • MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt.

Cymbiotika’s Launches Powerhouse Topical Magnesium Oil

Retrieved on: 
Wednesday, October 13, 2021
Other Consumer, Women, Other Retail, Fitness & Nutrition, Men, Other Health, Health, Consumer, Retail, View, Nervous system, Headache, Technology, Malnutrition, ZERO, Ageing, Longevity, Magnesium, Solvent, Nutrient, Lavandula, Torso, Tissue, Genetically modified organism, Diet, Sleep, Brain, Clothing, Egg, Multimedia, Skin, Health, Inflammation, Alcohol, BPA, Lactose, Dead Sea, Anxiety, Sugar, Flower, Magnesium oil, Dietary supplement, Feed manufacturing

Our topical magnesium oil is sourced from the Dead Sea, and combined with Pharmaceutical Grade DMSO, which makes it the most powerful and effective way to get magnesium into the body.

Key Points: 
  • Our topical magnesium oil is sourced from the Dead Sea, and combined with Pharmaceutical Grade DMSO, which makes it the most powerful and effective way to get magnesium into the body.
  • Cymbiotika Topical Magnesium Oil is scientifically formulated to absorb into the bloodstream within minutes, leaving no oily residue as compared to other topical magnesium products.
  • This magnesium oil is a great example of how Cymbiotikas supplementation science and technology continue to advance, said Cymbiotikas CEO/Managing Partner, Shahab Elmi.
  • While Cymbiotika offers the consumable Magnesium L-Threonate which nourishes the brain, the new topical Magnesium Oil targets tissues of the body reducing stress, tension and helps regulate nerve function.

Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-106 for the Treatment of Angelman Syndrome

Retrieved on: 
Tuesday, October 12, 2021
Health, Infectious Diseases, Genetics, Other Health, Research, Science, Biotechnology, Neurology, Nervous system, Therapy, Department, Learning, Central nervous system, Natural history, Associate, Drug development, FFPM, Pediatrics, MRCPCH, KOL, University of North Carolina at Chapel Hill, Assistant, Foundation, Psychiatry, AAV, Gene, CNS, Psychology, Patient, Disease, MRCP, Nasdaq, Pharmaceutical industry

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced it will host a virtual key opinion leader (KOL) webinar on TSHA-106 for the treatment of Angelman syndrome on Tuesday, October 26, 2021, from 10:00 a.m. to 1:00 p.m.

Key Points: 
  • Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced it will host a virtual key opinion leader (KOL) webinar on TSHA-106 for the treatment of Angelman syndrome on Tuesday, October 26, 2021, from 10:00 a.m. to 1:00 p.m.
  • A live video webcast will be available in the " Events & Media " section of the Taysha corporate website.
  • Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease.
  • With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside.

Intetics Team Has Developed A New Application That Helps Surgeons Navigate Neural Implant Insertion For A Medical Device Company

Retrieved on: 
Tuesday, October 12, 2021
CT, Association of British HealthTech Industries, AI, Nervous system, MPR, Algorithm, VTK, C, Memory, Intetics, ML, Case, Machine learning, Central nervous system, Client, Tissue, Thought, API, Software, Surgeon, MRI, FDA, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, 3D, Programmer, Multithreading, Stroke, Knowledge, Defense, CNS, Case study, Patient, Research, Technology, Head, DICOM, Dentistry, Medical device, Medical imaging

This is responsible for our seeing, thinking, moving, and feeling and it controls our cardiovascular, inflammatory, respiratory, and immune systems.

Key Points: 
  • This is responsible for our seeing, thinking, moving, and feeling and it controls our cardiovascular, inflammatory, respiratory, and immune systems.
  • Neural implants are highly invasive therefore, while implants have incredible medical potential, their use is limited.
  • Engineers are working on inventing medical devices that can reach deep into the body while having less of an impact on tissues.
  • Our Client is a medical device company that discovers, develops, and commercializes innovative medicines for people with serious diseases of the central nervous system (CNS).